Praxis Precision Medicines, Inc. PRAX Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number?
- Praxis Precision Medicines, Inc. (PRAX) reported share-based payment award options outstanding - number of 1.9M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number changed year-over-year?
- Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number decreased by 5.1% year-over-year, from 2.1M to 1.9M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s share-based payment award options outstanding - number has grown at a -20.6% compound annual growth rate (CAGR), from 5.9M to 1.9M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.